EAM-2201 (4′-ethyl-AM-2201 5-fluoro-JWH-210) is a drug that presumably acts as a potent agonist for the cannabinoid receptors. It had never previously been reported in the scientific or patent literature and was first identified by laboratories in Japan in July 2012 as an ingredient in synthetic cannabis smoking blends.
This page contains content from the copyrighted Wikipedia article "EAM-2201"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
